These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 15621576)
1. Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody. Larsson L; Mobini R; Aukrust P; Gullestad L; Wallukat G; Waagstein F; Fu M Autoimmunity; 2004; 37(6-7):489-93. PubMed ID: 15621576 [TBL] [Abstract][Full Text] [Related]
2. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508 [TBL] [Abstract][Full Text] [Related]
3. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients. Warraich RS; Dunn MJ; Yacoub MH Biochem Biophys Res Commun; 1999 Jun; 259(2):255-61. PubMed ID: 10362496 [TBL] [Abstract][Full Text] [Related]
4. Immunoadsorption as treatment option in dilated cardiomyopathy. Felix SB; Staudt A Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476 [TBL] [Abstract][Full Text] [Related]
5. Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy. Baba A Ther Apher Dial; 2008 Apr; 12(2):109-16. PubMed ID: 18387158 [TBL] [Abstract][Full Text] [Related]
6. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863 [TBL] [Abstract][Full Text] [Related]
7. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. Magnusson Y; Marullo S; Hoyer S; Waagstein F; Andersson B; Vahlne A; Guillet JG; Strosberg AD; Hjalmarson A; Hoebeke J J Clin Invest; 1990 Nov; 86(5):1658-63. PubMed ID: 1700798 [TBL] [Abstract][Full Text] [Related]
8. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. Fu LX; Magnusson Y; Bergh CH; Liljeqvist JA; Waagstein F; Hjalmarson A; Hoebeke J J Clin Invest; 1993 May; 91(5):1964-8. PubMed ID: 7683693 [TBL] [Abstract][Full Text] [Related]
9. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Shmilovich H; Danon A; Binah O; Roth A; Chen G; Wexler D; Keren G; George J Int J Cardiol; 2007 Apr; 117(2):198-203. PubMed ID: 16887211 [TBL] [Abstract][Full Text] [Related]
11. Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. Staudt A; Eichler P; Trimpert C; Felix SB; Greinacher A J Am Coll Cardiol; 2007 Apr; 49(16):1684-92. PubMed ID: 17448369 [TBL] [Abstract][Full Text] [Related]
12. Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor. Buvall L; Bollano E; Chen J; Shultze W; Fu M Clin Exp Immunol; 2006 Feb; 143(2):209-15. PubMed ID: 16412044 [TBL] [Abstract][Full Text] [Related]
13. Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells. Tutor AS; Penela P; Mayor F Cardiovasc Res; 2007 Oct; 76(1):51-60. PubMed ID: 17628514 [TBL] [Abstract][Full Text] [Related]
14. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects. Felix SB; Staudt A Int J Cardiol; 2006 Sep; 112(1):30-3. PubMed ID: 16860418 [TBL] [Abstract][Full Text] [Related]
15. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Jahns R; Boivin V; Lohse MJ Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696 [TBL] [Abstract][Full Text] [Related]
16. Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss. Konova E; Atanasova M; Stoykov S; Velkova A; Shoenfeld Y J Autoimmun; 2007 Feb; 28(1):46-54. PubMed ID: 17178213 [TBL] [Abstract][Full Text] [Related]
17. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841 [TBL] [Abstract][Full Text] [Related]
18. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975 [TBL] [Abstract][Full Text] [Related]
19. [Circulating autoantibodies against beta-adrenergic receptors in patients with heart diseases]. Li YY Zhonghua Yi Xue Za Zhi; 1992 Oct; 72(10):584-6, 638. PubMed ID: 1338502 [TBL] [Abstract][Full Text] [Related]
20. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases. Hurez V; Kaveri SV; Kazatchkine MD J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]